Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598702 · ClinicalTrials.gov registry record · Phase 3
Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients
A Phase 3 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00598702: Completed Phase 3 study, sponsored by Mallinckrodt.
NCT00598702 is a Phase 3 study that has completed, run by Mallinckrodt. The registered enrollment target is 100 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00598702, a Phase 3 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight
Primary Outcome
A TEAE is defined as an adverse event that starts on or after the start of study medication.
Interventions
- DRUG IV Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
What the finished NCT00598702 record still lists
NCT00598702 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which IV Acetaminophen is the first listed.
NCT00598702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00598702 about?
NCT00598702 is a clinical study titled "Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients". Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight
What is the current status of trial NCT00598702?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2008-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00598702?
The interventions under investigation include: IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT00598702?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00598702's enrollment target sits among peer trials
100 1681st of 2000 higher than 288 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia